Kong Vickie C, Dang Jennifer, Li Winnie, Navarro Inmaculada, Padayachee Jerusha, Malkov Victor, Winter Jeff, Raman Srinivas, Berlin Alejandro, Catton Charles, Warde Padraig, Chung Peter
Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.
Tech Innov Patient Support Radiat Oncol. 2022 Mar 2;21:64-70. doi: 10.1016/j.tipsro.2022.02.003. eCollection 2022 Mar.
To compare the dosimetry of prostate stereotactic radiotherapy (SBRT) delivered by adaptive intensity modulated radiotherapy (A-IMRT) and 3 degree of freedom volumetric modulated arc therapy (3DOF-VMAT).
METHODS & MATERIALS: Twenty-five prostate patients treated with High Dose Rate (HDR) brachytherapy followed by SBRT were included (fifteen with hydrogel spacer in place for treatment). Interfraction changes in the volume of prostate, rectum and bladder were measured. Fractional dose to these structures was estimated for A-IMRT and 3DOF-VMAT for comparison against the corresponding reference dose and between each other.
Clinically acceptable dose was delivered to prostate in all 125 fractions through A-IMRT and 3DOF-VMAT. A-IMRT was better than 3DOF-VMAT in reducing dose to 1 cm of rectum. Conversely, 3DOF-VMAT was superior in sparing 50% and 20% of rectum. When comparing the reference and delivered dose, there was no significant difference for Bladder D5cm for either technique. However, rectum in the high dose region benefited more from A-IMRT by being irradiated to a lower than reference dose in more fractions than 3DOF-VMAT. Hydrogel spacer reduced the rectal dose and was associated with a smaller deviation from reference dose for rectum D50% for A-IMRT.
Despite the presence of large interfraction organ volumes changes, clinically acceptable dose was delivered to the prostate by both systems. A-IMRT facilitated a greater rectal sparing from the high dose region than 3DOF-VMAT. Further reduction in rectal dose could be achieved by hydrogel spacer to displace the rectum, or by adaptation delivered by VMAT.
比较自适应调强放射治疗(A-IMRT)和三自由度容积调强弧形治疗(3DOF-VMAT)用于前列腺立体定向放射治疗(SBRT)的剂量学。
纳入25例接受高剂量率(HDR)近距离放射治疗后行SBRT的前列腺癌患者(其中15例在治疗时使用了水凝胶间隔物)。测量前列腺、直肠和膀胱体积的分次间变化。估算A-IMRT和3DOF-VMAT对这些结构的分次剂量,以与相应的参考剂量进行比较,并相互比较。
通过A-IMRT和3DOF-VMAT对所有125个分次的前列腺均给予了临床可接受剂量。在减少直肠1 cm处的剂量方面,A-IMRT优于3DOF-VMAT。相反,3DOF-VMAT在保护50%和20%的直肠方面更具优势。比较参考剂量和实际给予剂量时,两种技术的膀胱D5cm均无显著差异。然而,高剂量区域的直肠从A-IMRT中获益更多,因为与3DOF-VMAT相比,其在更多分次中接受的剂量低于参考剂量。水凝胶间隔物降低了直肠剂量,并且与A-IMRT的直肠D50%与参考剂量的偏差较小有关。
尽管存在较大的分次间器官体积变化,但两种系统均能对前列腺给予临床可接受剂量。与3DOF-VMAT相比,A-IMRT能更好地减少高剂量区域对直肠的照射。通过水凝胶间隔物使直肠移位或通过VMAT进行自适应调整可进一步降低直肠剂量。